METACARE CO., Ltd. (KRX:118000)
365.00
+16.00 (4.58%)
Feb 26, 2026, 9:50 AM KST
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 59.95 billion as of February 25, 2026. Its market cap has increased by 14.41% in one year.
Market Cap
59.95B
Enterprise Value
118.23B
Revenue
28.10B
Ranking
n/a
PE Ratio
46.86
Stock Price
365.00
Market Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has increased from 39.82B to 59.95B, an increase of 50.56%. That is a compound annual growth rate of 2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 62.01B | 18.36% |
| Dec 30, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.94T |
| Celltrion | 53.19T |
| ALTEOGEN | 21.71T |
| Sam Chun Dang Pharm. | 14.33T |
| Yuyu Pharma | 74.64B |
| Aprogen Biologics | 73.30B |
| MYUNGMOON Pharm co.,Ltd | 64.62B |
| HASS Corp. | 60.26B |